© 1999 Evidence-Based Mental Health
Equivalent response to methylphenidate in children with ADHD plus anxiety and those with ADHD only
Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J Am Acad Chil Adolesc Psychiatry 1999 Apr;38:4029.
Question Does comorbid anxiety moderate the response to methylphenidate in children with attention deficit hyperactivity disorder (ADHD)?
Randomised, double blind, placebo controlled, trial with 4 months follow up.
An outpatient, referral based, assessment and treatment programme for ADHD in a university clinic at The Hospital for Sick Children, Toronto, Ontario, Canada.
91 children between 6 and 12 years of age (mean age 8 y, 81% boys) with a confirmed diagnosis of ADHD beginning before 7 years of age were included. Exclusion criteria were: attended a full time residential or day treatment programme, received regular medication for a medical problem, had a primary anxiety or affective disorder (ie, the child required treatment for these disorders first), or had a chronic medical condition including a tic disorder or Tourette's syndrome. 38 children had comorbid anxiety disorder.
Children and their families were assigned to 1 of 4 treatment conditions: (1) methylphenidate plus parent training, (2) methylphenidate plus parent support, (3) placebo plus parent training, or (4) placebo plus parent support.
New York State Psychiatric Institute New York, New York, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
